Sun Pharma to acquire Novartis’s branded drug Odomzo
Posted on23 Dec 2016
Comments0
Sun Pharmaceutical Industries Ltd will acquire the NOVARTIS’s branded cancer drug Odomzo for an upfront payment of $175 million. Odomzo is a... Read More
Zydus acquires derma brand Melgain of Issar Pharma
Zydus Group firm Cadila Healthcare today said it has acquired Melgain lotion used for treatment of skin depigmentation from Issar Pharma to... Read More
Case Study: ORS L – J&J to acquire?
The world’s sixth largest consumer health and pharma giant Johnson & Johnson (J&J) has emerged as a front-runner to acquire electrolyte energy... Read More